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Abstract
Despite the fundamental importance of E. coli in the manufacture of a wide range of
biotechnological and biomedical products, extensive process and/or target optimisation is routinely
required in order to achieve functional yields in excess of low mg/l levels. Molecular chaperones
and folding catalysts appear to present a panacea for problems of heterologous protein folding in
the organism, due largely to their broad substrate range compared with, e.g., protein-specific
mutagenesis approaches. Painstaking investigation of chaperone overproduction has, however, met
with mixed – and largely unpredictable – results to date. The past 5 years have nevertheless seen
an explosion in interest in exploiting the native folding modulators of E. coli, and particularly
cocktails thereof, driven largely by the availability of plasmid systems that facilitate simultaneous,
non-rational screening of multiple chaperones during recombinant protein expression. As interest
in using E. coli to produce recombinant membrane proteins and even glycoproteins grows,
approaches to reduce aggregation, delay host cell lysis and optimise expression of difficult-to-
express recombinant proteins will become even more critical over the coming years. In this review,
we critically evaluate the performance of molecular chaperones and folding catalysts native to E.
coli in improving functional production of heterologous proteins in the bacterium and we discuss
how they might best be exploited to provide increased amounts of correctly-folded, active protein
for biochemical and biophysical studies.
Background
E. coli is preferred for heterologous protein production
because of its fast growth, simple fermentation, uncom-
plicated nutritional and sterility requirements, and exten-
sive characterisation [1]. Despite its widespread use [2],
however, many heterologous proteins are produced as
insoluble aggregates in cytoplasmic or periplasmic inclu-
sion bodies, while the membrane leakiness and cell lysis
associated with making heterologous proteins in E. coli,
leading to significantly reduced yields, have also been well
documented [3,4].
The discovery of molecular chaperones and folding cata-
lysts appeared to present a panacea for protein aggrega-
tion and cell lysis problems in E. coli [5-7]. Molecular
chaperones prevent aggregation by binding exposed
hydrophobic moieties in unfolded, partially folded or
misfolded polypeptides and traffic molecules to their sub-
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cellular destination, while folding catalysts catalyse
potentially rate-limiting steps in the folding process, such
as peptidyl bond isomerisation or disulfide bond forma-
tion. Painstaking investigation of these molecules has met
with disparate results to date as simple overexpression of
a single modulator in the absence of its accessory mole-
cules frequently sees no positive effect – and may simply
increase the production load to the further detriment of
the recombinant target. In the absence of an ability to pre-
dict the relevant bottleneck in E. coli, therefore, an increas-
ingly common approach by researchers is the use of
chaperone "cocktails", which is facilitated by the recent
availability of a number of plasmid systems that can be
used to co-produce up to 6–7 folding modulators with a
heterologous protein [8,9].
A universal system of producing active, recombinant pro-
teins in E. coli remains a core objective of the biotechnol-
ogy industry. In this paper, we review progress in
exploiting folding modulators from E. coli to improve the
functional production of heterologous proteins.
Folding in the cytoplasm
The major groups of molecular chaperones involved in
protein folding in the E. coli cytoplasm are the peptidyl-
prolyl cis-trans isomerase and molecular chaperone trigger
factor (TF) and members of the heat shock protein Hsp70
and Hsp60 families, in addition to ClpB that disaggregates
polypeptide aggregates and the small heat shock proteins.
The process of polypeptide folding in the E. coli cytoplasm
and the chaperones involved are summarised in Figure 1.
The process of protein folding in the E. coli cytoplasm Figure 1
The process of protein folding in the E. coli cytoplasm. Nascent polypeptides encounter trigger factor (TF) chaperone 
upon emerging from the ribosomal exit tunnel (1). They can also be captured by DnaK (2) which cooperates with its cofactor 
DnaJ and nucleotide exchange factor GrpE to promote folding to a native (3) or partially folded conformation. The latter may 
be re-captured by DnaK (4) and possibly TF to repeat this folding cycle until it reaches its native state, interact with GroEL-
GroES (5) to complete folding to its native conformation, or undergo aggregation (6). Upon heat stress, partial unfolding of 
thermolabile proteins can occur, resulting in exposure of aggregation-prone hydrophobic regions (7). sHsps such as IbpA and 
IbpB act to "hold" partially unfolded proteins for transfer to Hsp70 and Hsp60 chaperones DnaK and GroEL (8,9), while disag-
gregation of unfolded proteins is carried out by ClpB in cooperation with the Hsp70 family (10), followed again by their trans-
fer to the DnaK/DnaJ/GrpE machinery for completion of folding.Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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Cytoplasmic PPIases
Most peptide bonds are synthesised in the trans conforma-
tion at the ribosome but both the cis and trans conforma-
tions are accessible in peptides. As a result, cis-trans
isomerisation of peptidyl-prolyl bonds is a potentially
rate-limiting step in the folding process (reviewed in
[10]). TF is a cytoplasmic enzyme with PPIase activity and
the first chaperone to interact with nascent polypeptides
at the ribosome (Figure 1). While it binds the ribosome at
a 1:1 ratio [11,12], most TF in the cell is proposed to exist
in a monomer-dimer equilibrium in the cytosol [13], in
which the dimeric state is postulated to have a specific
mechanistic role in posttranslational protein folding [14].
The activity of TF in supporting polypeptide folding over-
laps at least in part with that of the downstream Hsp70
protein DnaK, as evident from the fact that the loss of
either chaperone can be tolerated by E. coli but their com-
bined deletion is lethal under normal growth conditions
[15].
Overproduction of trigger factor
As TF displays both chaperone and PPIase activity in vivo
and in vitro [16,17], it has been the subject of considerable
interest in co-production experiments – despite the fact
that the majority of newly synthesised polypeptides do
not require it for de novo folding [18]. Nevertheless, TF co-
production led to a 4-fold increase in expression of an
anti-digoxin Fab antibody fragment in the E. coli cyto-
plasm [19] and a higher yield of soluble human ORP150
and lysozyme [17], with further improvements in expres-
sion and solubility achieved in the latter case by co-over-
producing the Hsp60 GroESL. Similarly, a 3.8-fold
increase in the solubility of human translation initiation
factor eIF2α was noted upon TF and GroESL co-overpro-
duction [20], though the addition of GroESL to successful
TF co-production experiments can also be un- [17] or
counter-productive [21].
TF co-production can also be synergistic with that of
Hsp70 family members DnaK-DnaJ-GrpE, as observed in
a temperature-dependent effect on guinea pig liver trans-
glutaminase production [22] and vasostatin [23], which
may be linked to TF's reported in vivo role in enhancing
cell viability at low temperatures [24]. In an attempt to
determine the mode of action of TF, mutants with very
low PPIase activities were found to enhance soluble pro-
duction of an adenylate kinase to the same extent as
wildtype TF [25], indicating that the effect of TF on at least
some recombinant proteins may be due to its chaperon-
ing rather than isomerisation activity. The observation
that human FKBP12, which has PPIase but no chaperone-
like activity, did not improve expression of a thiosulfate
sulfurtransferase enzyme that benefitted from co-produc-
tion of an archaeal FKBP [26] provides additional evi-
dence that many of the positive effects of PPIases in
foreign protein production may relate to their chaperone-
like rather than their isomerisation activity.
Hsp70 family
The heat shock protein 70 (Hsp70) family of proteins are
ubiquitous, highly conserved molecules whose predomi-
nant unifying feature is the ability to bind short, linear
hydrophobic regions of polypeptides [27,28]. In addition
to their role under heat stress, they assist in folding of
newly translated polypeptides and subcellular trafficking
of polypeptides under normal physiological conditions.
Members of the family contain an ATPase domain and a
more variable, peptide-binding domain and polypeptide
binding and release is carried out in a cycle between an
ATP-bound DnaK molecule with low substrate affinity
and a high substrate affinity, ADP-bound state [29].
The activity of DnaK is dependent on the proteins DnaJ
and GrpE in E. coli. DnaJ contains a highly conserved N-
terminal region that interacts with DnaK, followed by a
glycine/phenylalanine-rich region, a zinc finger domain
that mediates polypeptide binding, and a variable C-ter-
minal domain [29-31]. Following transient association
between DnaK and DnaJ with concomitant ATP hydroly-
sis, GrpE catalyses the release of ADP from the DnaK-
ADP-peptide complex. In this state, ATP is rapidly
rebound by DnaK, leading to release of the bound
polypeptide and of GrpE. This cycle of binding and release
may be repeated many times, with the released peptide
either recommencing the DnaJ/DnaK cycle, being trans-
ferred to the chaperonin GroEL, undergoing further fold-
ing steps to reach its native state, or aggregating (Figure 1;
[32]).
Overproduction of DnaK-DnaJ-GrpE with cytoplasmic proteins
DnaK-DnaJ-GrpE chaperones are most commonly over-
produced with cytoplasmic recombinant proteins, due to
their own location in the cytoplasm. This approach has
enabled the successful production of a number of proteins
otherwise produced mainly or exclusively as inclusion
bodies, such as a single-chain antibody fragment (scFv;
[33]), human tyrosine kinases Csk, Fyn and Lck [34], an
Acinetobacter cyclohexanone monooxygenase [35], and a
cedar pollen allergen [36]. DnaK-DnaJ without GrpE have
also been reported to increase production (red sea bream
transglutaminase; [37]), suppress aggregation (human
SPARC – secreted protein acidic and rich in cysteine;
[38]), improve solubility (Agrobacterium D-hydantoinase;
[39]), and increase the activity (β-galactosidase fusion
protein; [40]) of numerous recombinant proteins. This
improved production is generally due to increased solu-
bility of recombinant targets rather than an increase in cel-
lular production levels, though Nishihara and co-workers
[17] reported a decrease in total murine endostatin con-
comitant with increased levels of soluble protein uponMicrobial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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DnaK-DnaJ-GrpE overproduction. It should, however, be
noted that increased solubility is not always accompanied
by an increase in protein quality and so determination of
solubility may not always provide an accurate picture of
correct folding, as reported in a study of the effects of
DnaK levels on a misfolding-prone GFP fusion protein
[41,42].
Conversely, DnaK-DnaJ have little effect on the solubility
and negative effects on the production and activity of
numerous proline-rich targets [17,39,43], which empha-
sises the benefits of attempting to "match" chaperones to
hypothetical bottlenecks in target protein production.
Other workers have reported that protein aggregation
could be prevented when DnaK-DnaJ-GrpE were co-
expressed at 2–3 times wild type levels but that higher
chaperone concentrations resulted in a reduced yield of
recombinant protein [36]. These results highlight a recur-
ring theme in this field, that chaperone overproduction
must be regulated to meet the additional needs of the host
cells, rather than serving to add to cellular stress through
the high-level production of an irrelevant protein product
[44].
The relatively recent availability, both commercial and
non-commercial, of sets of E. coli chaperone co-produc-
tion plasmids carrying the groESL,  dnaKJ grpE,  tig  and
other chaperone genes, frequently under independently
regulated promoters, has led to numerous co-production
analyses of Hsp70 proteins in combination with GroESL
and trigger factor in particular. The successes reported
with a variety of molecules from combining chaperones
in this manner [17,44-47] and the ease of carrying out
such broad screens means this type of approach will con-
tinue to provide an obvious starting point for researchers
looking to improve expression of otherwise intransigent
proteins.
Overproduction of Hsp70 family members with periplasmic proteins
Hsp70 co-production has also been employed to benefi-
cial effect with heterologous proteins produced in the E.
coli periplasm, apparently by increasing the solubility of
the protein precursor prior to membrane translocation. A
100-fold increase in the yield of a scFv antibody fragment
was observed upon co-producing DnaK-DnaJ-GrpE [48],
while export of human granulocyte-colony stimulating
factor [49], granulocyte-macrophage colony-stimulating
factor and interleukin-13 [50] were greatly improved
upon production of DnaK and DnaJ. In all cases, the
amount of total cellular protein remained unchanged. A
variation on this approach saw export of DnaJ itself to the
E. coli periplasm, leading to dramatic (37- to 170-fold)
increases in the functional periplasmic yields of a tissue
plasminogen activator (tPA) variant and of proinsulin
[51] – though no positive effect was found on a scFv-gene
3 protein fusion in the same study.
Hsp60 family
The Hsp60 family is the most studied of all the chaperone
families and is composed of GroEL and its homologues in
prokaryotes, chloroplasts and mitochondria, and the
TRiC/TCP-1 family in the eukaryotic cytosol. GroEL is
characterised by a fascinating double ring-shaped struc-
ture composed of 14 identical subunits, stacked in 2 back
to back heptameric rings, which together form a hollow
cylinder containing a nucleotide binding site facing into
the central channel [52]. GroEL acts by binding unfolded
polypeptide at either of the outer ends of its inner cavity
through hydrophobic interactions [53,54]. This is fol-
lowed by capping of the cavity by its Hsp10 family co-
chaperonin GroES, which exists as a single heptameric
ring with a hollow dome-shape structure [55] to create a
closed environment, with a capacity of approximately 86
kDa [56], in which substrate folding is favoured. Cycles of
peptide binding and release are driven by ATP binding
and hydrolysis, promoting a structural stretching of the
guest protein until a sufficiently native state is reached
such that exposed hydrophobic regions are no longer
available to be bound in the GroEL cavity [57]. The dem-
onstration that GroESL mediated folding of an 82-kDa
aconitase protein that could not be encapsulated in the
central GroEL cavity led more recently to the identifica-
tion of a less efficient trans mechanism of polypeptide
folding by GroEL, in which polypeptides are not encapsu-
lated and the chaperone appears to act more as a holdase,
suppressing off-pathway aggregation reactions, than as a
foldase ([58]; reviewed in [59]).
Overproduction of GroESL with cytoplasmic, periplasmic proteins
Overproduction of GroESL has proven a highly produc-
tive approach to overcoming polypeptide folding prob-
lems in E. coli, allowing the soluble production of many
recombinant proteins which are otherwise produced
exclusively or almost exclusively in inclusion bodies.
These include proteins as diverse as human thromboxane
synthase [60], nicotinoprotein formaldehyde dismutase
from Pseudomonas putida F61 [61], human oxygen-regu-
lated protein ORP150 and human lysozyme [17], a
human iron-regulatory protein [62], a putative bacterial
dehydratase [63], β-glucosidases from Cellovibrio gilvus
and Agrobacterium tumefaciens [64], murine c-Myb, cAMP
response element-binding protein 1, p53 tumour suppre-
sor gene product, Xenopus mos proto-oncogene product
[65], bacterial magnesium transporter CorA [66] and tri-
azine hydrolase from Arthrobacter aurescens TC1 [67]. A
sample of proteins whose total or functional yield in the
E. coli cytoplasm is merely increased upon GroESL over-
production, meanwhile, can be found in Table
1[19,21,36,39,43,58,61,64,68-101].Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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Table 1: Proteins whose total and/or functional yields increase upon co-production of GroESL
Recombinant protein Effect of co-production of GroESL chaperones Reference
Human procollagenase GroESL increased production levels by 10-fold, solubility and half-life [68]
p50csk Protein-Tyrosine Kinase Co-production enhanced solubility and activity of the protein by up to >50% [69]
Candida albicans PMI metalloenzyme 2-fold increase in protein solubility [70]
α and β subunits of human propionyl-CoA 
carboxylase (PCC)
Several hundred-fold increase in PCC specific activity; most of the protein 
produced in soluble form
[71]
Human electron transfer flavoprotein (ETF) Co-production required for stable expression of ETF α G116R mutant [72]
β-glucosidase from Cellovibrio gilvus and 
Agrobacterium tumefaciens
Co-production resulted in slower growth rate and reduced yield but increased 
solubility of the proteins by 20–60% at 37°C and up to 70% at 25°C
[64]
Cryj2 Japanese cedar pollen Increased yield and solubility of expressed protein; 4-fold stabilisation of the protein 
in the presence of a 10-fold chaperone excess
[36]
Human kinase inhibitor-GST fusion Solubility of otherwise mostly insoluble protein enhanced by 5–6-fold [73]
Eukaryotic phenylalanine ammonia-lyase Dramatically improved yield and activity of the protein after engineering of gene to 
remove E. coli rare codons
[74]
Bovine adrenodoxin reductase (AdR) Increased soluble AdR yield to 10 mg/l, compared with 4 mg/l with Hsp70 [75]
Cyanobacterium transcription factor 3–4-fold increase in solubility [76]
Thermococcus litoralis 4-α-glucanotransferase 
(GTase)
Co-production of GroESL with tRNAAGA and tRNAAGG led to 5-fold increase in 
GTase activity in soluble fraction; yield otherwise lower and 60% insoluble
[77]
Agrobacterium radiobacter carbamoylase 4-fold increase in activity due to improved solubility [39]
Human cytochrome P450 3A7 (CYP3A7) Increased expression levels and activity of the otherwise inactive protein [78]
Decarboxylase component of human α-keto acid 
dehydrogenase complex
Co-production of GroEL or GroES resulted in increase in decarboxylase activity by 
500-fold and 30-fold, respectively
[79]
Maize plastidic protoporphyrinogen IX oxidase 
(PPO)
6-fold increase in soluble PPO yield [80]
Manganese catalase from Thermus sp. Increased solubility (up to 50%) with GroESL [81]
p66 and p51 subunits of HIV-1 RTase Yield and nucleic acid affinity increased by 4–5- and 1.6-fold, respectively [82]
Anti-digoxin Fab antibody fragment 4-fold increase in solubility of the Fab produced in E. coli Origami strain [19]
Agrobacterium tumefaciens D-carbamoylase (DCB) Increase in solubility of DCB up to 60% and activity by 6.2-fold at 28°C; at 25°C 
protein solubility increased to 75% and activity by 4.5-fold
[83]
Guinea pig NADPH:quinone oxidoreductase 3-fold increase in solubility [84]
Aconitase Solubility and activity increased to 40% and by 1.5-fold, respectively [58]
Rhodococcus erythropolis desulfinase Solubility of the protein increased up to 40–50% and activity by 25-fold [85]
E. coli glutamate racemase (GluR) Growth of host cells improved; 2.2-fold increase in yield of active GluR [86]Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
Page 6 of 17
(page number not for citation purposes)
In spite of this impressive track record and the fact that
GroEL has been demonstrated to support the folding of a
majority of newly translated polypeptides in E. coli [54],
GroESL overproduction is still not the much sought-after
magic bullet for heterologous protein folding in E. coli.
There are numerous reports of GroESL failing to improve
protein solubility [102] or rescue recombinant proteins
from inclusion bodies [103], even where co-production of
Hsp70 family members was successful [22,37,48]. Over-
production of GroESL has also been found to lead to
reduced enzyme activity [21] and lower viability of host
cells during protein production [48]. These failings may
reflect a degree of polypeptide specificity on the part of
GroESL, as potentially evident in its differing effects on
the expression of two human aromatase variants that dif-
fer only by a single amino acid residue [94]. Similarly, as
discussed above with Hsp70 family members, GroESL
overproduction has notably failed to improve the produc-
tion of proteins with complex disulfide patterns
[38,104,105] or in which peptidyl-prolyl cis-trans isomer-
isation is limiting [106] as the production bottleneck in
such cases presumably lies outwith the remit of its chap-
eroning role.
Co-overproduction of GroESL with DnaK-DnaJ-GrpE
and/or TF has led to numerous notable successes over
those achievable with GroESL alone, such as with a
human translation initiation factor [20], human oxygen-
regulated protein ORP150 and human lysozyme [17], a
D-aminoacylase [21] and, in temperature-dependent
Pseudomonas putida F61 nicotinoprotein 
formaldehyde dismutase (NDF)
With tac promoter, increased solubility (up to 80%) and 6-fold higher enzyme 
activity; lesser effect when NDF expressed under the lac promoter
[61]
Human PP2A methyltransferase 24-fold increase in solubility [87]
Oligo-1,6-glucosidase from Bacillus 
thermoglucosidasius
Specific activity increased by 44%, 56% and 56% with co-production of GroES, 
GroEL and GroESL, respectively
[43]
Cyclodextrin gluanotransferase (CGTase) from 
Bacillus macerans
Increase in solubility and activity of CGTase by 12% and 1.5-fold, respectively, at 
37°C and by 22% and 1.3-fold, respectively, at 25°C
[88,89]
Rhizobium sp. α-1,6-fucosyltransferase At 30°C, improved folding and an increase in specific activity by 1.76-fold [90]
Mouse CYP27B1 protein 10-fold increase in the yield of stable and active protein [91]
Pyridoxine 4-oxidase (PNO) from Microbacterium 
luteolum
No benefit of GroESL at 37°C; co-production at 23°C enhanced solubility and 
specific activity of PNO by 1.9-fold and 3.9-fold, respectively
[92]
Pyridoxal 4-dehydrogenase from Microbacterium 
luteolum
Co-production at 20°C led to reduced amounts of insoluble protein and increased 
specific activity by 9.1-fold
[93]
Alcaligenes xylosoxydans N-acyl-D-amino acid 
amidohydrolases
Enzymatic activity of the proteins increased from 7.8 to 72.4 U/mg and 7.1 to 22.7 
U/mg, respectively, at 30°C
[21]
Human aromatase (P450arom, CYP19) 
NmA264C and NmA264R mutants
No improvement with NmA264C; production of NmA264R greatly enhanced 
(up to 400 nmol/l)
[94]
scFv specific for c-Met Solubility increased 2-fold in E. coli Origami2(DE3) but not in BL21(DE3) [95]
Yeast mitochondrial aconitase Increased solubility at 25°C with no change in total yield [96]
human prolyl hydroxylase isoenzyme 2-fold increase in solubility when produced at 30°C [97]
Pig liver esterase γ-isoenzyme (PLE) Enhanced yield of soluble and active PLE in E. coli Origami (DE3) [98]
Soybean seed ferritin complex Increased solubility of H-1 subunit from 4 to 39% and H-2 subunit from 19 to 85% [99]
Human 11β hydroxylase 20- to 40-fold increase in yield in half the production time [100]
Human glucose 6-phosphate dehydrogenase 
(G6PD) and mutants
Negligible effect on expression of wild type G6PD but activities of two mutants 
were enhanced by 48–160% and 39–118% at 37°C and 31°C, respectively
[101]
Table 1: Proteins whose total and/or functional yields increase upon co-production of GroESL (Continued)Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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effects, with a GST-human vasostatin fusion protein [23]
and human endostatin [45], all in combination with TF.
Combining GroESL with DnaK-DnaJ-GrpE has proven
significantly less fruitful, with numerous examples of
losses (up to total) of positive effects on solubility or activ-
ity upon addition of the second chaperone family to the
experimental setup [21,33,48,107]. As these multi-chap-
erone experiments usually have the singular objective of
increasing target protein yields, however, they typically
lack the detailed mechanistic studies necessary to deline-
ate the effects of individual chaperones. In one attempt to
delineate the respective roles of the Hsp60 and Hsp70
families in the cytoplasmic production of a penicillin acy-
lase (PAC) precursor (proPAC), however, Xu and co-
workers reported that the effect of GroESL co-production
was to prevent intracellular proteolysis while DnaK-DnaJ-
GrpE led to improved solubilisation of proPAC and
improved PAC maturation [108].
While some success has resulted from co-producing chap-
erones such as DnaK with periplasm-destined recom-
binant proteins, comparably little success has accrued
with GroES and GroEL. Thus it appears that, while GroESL
overproduction represents a prime choice for investiga-
tion of folding defects of recombinant proteins expressed
in the cytoplasm, it is typically unable to overcome bottle-
necks associated with periplasmic production.
Overproduction of Hsp60 and Hsp70 members with membrane 
proteins
Recombinant production of membrane proteins in E. coli
presents very particular and complex challenges to the
bacterial host. There are few reports of co-production of
molecular chaperones with membrane proteins in E. coli
due to the paucity of reports of recombinant membrane
protein produced successfully in the host in general.
Amongst these, the expression and solubility of the HrcA
repressor from Helicobacter pylori were dramatically
increased upon induction of heat shock proteins by ele-
vated temperature [109] while overexpression of GroESL
led to significantly improved expression of the human
liver cytochrome P450 2B6 [110] and a DnaK-DnaJ com-
bination reduced inclusion body formation by the CorA
bacterial magnesium transporter [66]. While the present
body of literature does not make a particularly compelling
case for adding chaperones to membrane protein produc-
tion experiments in E. coli, screening of their influence in
such set-ups is clearly advisable due to the simplicity and
low cost of the approach, and their potential benefits on
the passage through the cytoplasm and/or periplasm of
these often highly hydrophobic and difficult-to-express
proteins.
Small heat shock proteins
Small heat shock proteins (sHsps) are a ubiquitous group
of proteins that tend to exist in vivo as macromolecular
complexes, the stoichiometry of which varies between dif-
ferent sHsps (reviewed in [111]). They bind non-native
proteins with a high degree of promiscuity in an ATP-
independent manner and their slowness of substrate
release has led to speculation that they may function pri-
marily as reservoirs of unfolded protein in times of stress.
It is also likely that, upon removal of the physiological
stress, they interact with other chaperones such as the
Hsp70 group, leading to peptide release and ATP-depend-
ent folding [111,112]. Their native activity has led to
some interest recently in their potential usefulness in
increasing the solubility of heterologous proteins in E.
coli.
E. coli IbpA and IbpB have been demonstrated to protect
misfolded proteins from irreversible aggregation and are
thought to help to resolubilise protein aggregates [113-
115]. Overproduction of IbpAB led to increased produc-
tion of E. coli malic enzyme, enhanced green fluorescent
protein, and human IGF-If, interferon γ and interleukin-
12 β chain by 1.3- to 2-fold in the E. coli cytoplasm [116],
as well as increased soluble yields of 17 of 23 proteins,
many difficult to express, in an extensive investigation of
overproduction of the entire network of major E. coli
cytosolic chaperones ([47] see also [46]). Increased yields
of soluble proteins were also obtained upon co-overpro-
duction of IbpAB with DnaK-DnaJ-GrpE, ClpB and
GroESL, albeit only to levels attainable upon addition of
the heat shock-inducer benzyl alcohol [117]. Conversely,
overproduction of IbpAB could not suppress inclusion
body formation by preS2-S'-β-galactosidase [118], while
successful production of a human GTPase activating pro-
tein, which led to cell lysis under standard expression con-
ditions, could be achieved only in a ΔibpAB E. coli strain
[119]. Co-production of hexadecameric murine Hsp25,
meanwhile, fused to an ompA signal peptide, increased the
amount of functional tPA variant in the E. coli periplasm
by 125-fold [51] but there was no increase in the periplas-
mic yield of native proinsulin in the same study.
de Marco and co-workers recently presented an extensive
evaluation of the effects of coproduction of IbpAB in asso-
ciation with Hsp70, Hsp60 and ClpB proteins [46,47]. In
their approach, protein production (and chaperone co-
production) was followed by a period of inhibition of
protein synthesis to allow chaperone-mediated refolding
of misfolded or aggregated polypeptides. The overall
effect of co-overproduction of IbpAB was an increase in
the solubility of 20 of 23 proteins tested, including 12 that
could not be produced in soluble form in the absence of
IbpAB [47].Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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Miscellaneous accessory molecules
In additional to "conventional" chaperones, the ability of
a variety of accessory proteins to improve recombinant
protein production and/or activity in E. coli has been eval-
uated. One of the most common of these is thioredoxin
(Trx), as discussed later in the context of disulfide bond
metabolism. ClpB, meanwhile, is a large, star-shaped hex-
americ molecule that interacts with the DnaK chaperone
system in a currently unresolved manner to disaggregate
insoluble polypeptide aggregates (reviewed in [120]). It is
postulated to unfold and pass polypeptides through its
central, 13-Å channel [121,122] and is an obvious candi-
date for overproduction given its recognised ability to dis-
aggregate polypeptide aggregates. This potential is borne
out by the observation that, while various combinations
of Hsp60 and Hsp70 proteins could dissolve macromo-
lecular aggregates of human basic fibroblast growth fac-
tor, this typically was not concomitant with increased
solubility of the target unless ClpB was also overproduced
[44]. Overproduction of tRNA molecules specific for E.
coli rare codons, often carried out in combination with
conventional chaperone co-production, has also been
commonly used to increase yields of proteins from species
with a codon bias significantly different from that of E.
coli, including archaeabacteria [77], Plasmodium  [123],
viruses [124] and eukaryotes [125].
A further approach to chaperoning heterologous proteins
in E. coli is to provide their native chaperone or accessory
protein where possible, as in the case of co-production of
the rubisco-specific chaperone RbcX with Synechococcus
ribulose-1,5-biphosphate carboxylase/oxygenase [126].
The activity of 17α-hydroxylase-C17,20-lyase (P450cl7)
also increased 100-fold upon co-production of rat
NADPH-cytochrome-P450-reductase [127] while the sol-
ubility of human retinoic acid receptor [128] and α-subu-
nits of human haemoglobin [129] increased upon co-
production of their binding partner and specific stabilis-
ing chaperone, respectively.
Secretion from the cytoplasm
Proteins destined for the non-reducing environment of
the periplasm are most commonly secreted using the Sec
(secretion) family [130]. Cytosolic SecB associates with
unfolded proteins in an ATP-independent manner and
delivers them to SecA, the site of preprotein entry into the
membrane-bound translocase [131,132]. Translocation is
achieved through the SecEY complex, which forms a pore
through which the preprotein passes [133,134], and
involves the action of SecG, which "lubricates" the pore
for insertion of a SecA domain [133,135]) and SecD and
SecF, which prevent reverse translocation of the prepro-
tein [133].
In addition to the sec pathway, a less well characterised
twin-arginine translocation (tat) pathway of membrane
translocation also exists [136]. The essential components
of this pathway are the TatA, TatB and TatC integral mem-
brane proteins, which recognise a critical twin arginine
motif in the N-terminal signal sequence of polypeptide
substrates. Unlike the sec  system, the Tat pathway can
transport proteins across the cytoplasmic membrane in a
fully folded state (Figure 2; [136,137]). Furthermore, two
distinct systems, the first employing a homologue of the
eukaryotic signal recognition particle called the fifty-four
homologue (Ffh; [138]) and its FtsY receptor and the sec-
ond the 61-kDa cytoplasmic protein YidC [139], are
involved primarily in targeting integral membrane
(pre)proteins to the inner membrane in E. coli. The possi-
ble membrane translocation routes of recombinant
polypeptides, and their subsequent folding in the peri-
plasm, are represented in Figure 2.
Improving the process of secretion
While manipulation of the Sec pathway initially concen-
trated largely on the SecEY tranlocase, the disappointing
results led to most studies focussing instead on the SecA
and SecB proteins that deliver polypeptides to the translo-
case. Even then, results remained unspectacular: SecB
overproduction resulted in increased solubility and a
higher yield of a penicillin acylase, though enzyme activ-
ity was not increased [140], while SecB and SecF overpro-
duction led to 3- and 2-fold increases, respectively, in the
periplasmic activity of a penicillin amidase [141].
Comparatively little analysis of tat gene overexpression
has been carried out, though overexpression of tatABC, in
combination with manipulation of physiological condi-
tions, led to a 20-fold increase in the level of a green fluo-
rescent protein that otherwise rapidly saturates the tat
translocation machinery [142]. Co-expression of phage
shock protein A (PspA) can also relieve saturation of pro-
tein export via this pathway [143] while Han and co-
workers [116] demonstrated that knocking out the sHsps
IbpA and IbpB led to enhanced secretion of enhanced
green fluorescent protein (EGFP) from Aequorea victoria
via both the sec and tat secretion pathways. The recent
demonstration that DnaK and SlyD chaperones serve as
general Tat signal-binding proteins [144,145], in tandem
with the promising outcomes of the limited investigation
of the pathway to date, is likely to focus increased atten-
tion on using the tat machinery to improve periplasmic
expression over the coming years.
Meanwhile, in the only evaluation of Ffh overproduction
reported to date, co-overexpression of ffh/ffs (the latter
encoding 4.5S RNA) or ffh/ffs/ftsY with the bacterial inner
membrane magnesium transporter CorA led to reducedMicrobial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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expression of CorA and failed to prevent inclusion body
formation [66].
Overall, while E. coli strains that allow formation of
disulfide bridges in the cytoplasm are now available, thus
negating the need for secretion of disulfide-containing
recombinant proteins, there is little evidence that the
secretion process limits the production of most heterolo-
gous proteins. Instead, the bottleneck for production is
usually more likely to involve maintenance of polypep-
tides in a non-aggregated, translocation-competent form
in the cytoplasm or in avoidance of aggregation in the
periplasm subsequent to membrane translocation.
Folding in the periplasm
Following membrane translocation, folding of the heter-
ologous polypeptide takes place in the periplasmic space
(Figure 2). While disulfide bond formation and peptidyl-
prolyl cis-trans isomerisation can occur here, no general
molecular chaperones that prevent non-productive fold-
Membrane translocation and periplasmic folding in E. coli Figure 2
Membrane translocation and periplasmic folding in E. coli. Most polypeptides cross the cytoplasmic membrane in an 
unfolded conformation using the Sec translocase (1), following delivery to SecA at the inner surface of the membrane by DnaK 
or SecB chaperones. Polypeptides with highly hydrophobic signal sequences or transmembrane domains may, however, be rec-
ognised by Ffh which, together with its FtsY receptor, can target the polypeptide to either the Sec machinery or to the YidC 
translocase (2). Alternatively, the twin-arginine translocation (Tat) machinery is responsible for the translocation of already 
folded proteins (3), typically with bound metal cofactors. After cleavage of the leader peptide upon crossing the membrane, 
partially folded proteins may (4) aggregate, (5) be degraded by periplasmic proteases, or fold into their native state, often with 
the assistance of periplasmic chaperones (6) and/or folding catalysts such as disulfide bond metabolising enzymes (7) or pepti-
dyl-prolyl cis-trans isomerases (8).Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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ing reactions had been identified until relatively recently,
when a variety of molecules such as Skp, FkpA, SurA and
DegP were independently isolated and characterised.
Skp is an E. coli periplasmic seventeen kiloDalton protein
that has been found to assist the production of difficult-
to-express antibody fragments in particular. Skp co-pro-
duction led to delayed cell lysis and improved production
of single-chain antibody fragments (scAbs; [146]), higher
yields and increased antigen binding activity of scFvs
[147], improved functional production of phage-dis-
played scFvs [148] and improved production and secre-
tion of a Fab fragment [149]. Meanwhile, a signal
sequence-less Skp has also been used to increase the yield
of active Fab fragment in the cytoplasm of an E. coli Ori-
gami strain [19]. Skp co-production has also been utilised,
in combination with protein engineering, to achieve high-
level secretion of three single-chain T cell receptors [150],
which, though structurally similar to antibody fragments,
have traditionally proven difficult to produce in active
form in E. coli. Skp has been also found to enhance the E.
coli cell surface display of a yellow fluorescence protein by
reducing the extracytoplasmic stress and, thus, improving
cell physiology [151].
DegP is a periplasmic protease that is proposed to
undergo a shift to function as a chaperone at low temper-
atures, though it has recently been demonstrated to retain
proteolytic activity as low as 20°C [152]. It is active in the
same pathway as Skp, with SurA active in a parallel chap-
erone pathway. DegP overproduction has been found to
reduce inclusion body formation in the periplasm and to
increase the activity of penicillin acylase in E. coli
[153,154], while SurA and FkpA chaperones possess PPI-
ase activity in addition to their chaperone functions and
are discussed later.
Manipulation of the disulfide bond metabolic machinery
Formation of stable disulfide bonds is confined to the oxi-
dising periplasmic environment in E. coli, where disulfide
bond formation, reduction and isomerisation are cata-
lysed by the Dsb (disulfide bond formation) family in a
thiol-disulfide exchange between their active site Cys-X-X-
Cys cysteines and those of the target protein (reviewed in
[155]). DsbA catalyses disulfide bond formation by trans-
ferring its own active site disulfide to the target protein,
leaving DsbA in a reduced form, whereupon it is reoxi-
dised by the cytoplasmic membrane-bound DsbB. DsbB
in turn passes its electrons to the respiratory chain to
regenerate its own oxidised state. "Shuffling", or isomeri-
sation, of incorrectly-formed disulfide pairs is carried out
by DsbC, which is maintained in its reduced form by the
cytoplasmic membrane-bound DsbD [156,157]. Other
Dsb proteins in E. coli include DsbE, which is required for
cytochrome c biogenesis, and DsbG, which catalyses
disulfide bond formation but is an inefficient catalyst of
disulfide rearrangement.
DsbA and DsbC in particular are commonly co-produced
with disulfide-linked recombinant proteins in the peri-
plasm, an approach which has met with considerable suc-
cess. DsbA overproduction has led to increased functional
yields of numerous proteins, such as heat-labile entero-
toxins [158], as well as increased solubility of human lep-
tin [159] and cyclohexanone monooxygenase [35]. DsbC
has now become the Dsb protein of choice, however, par-
ticularly when producing proteins with complex disulfide
patterns such as tissue plasminogen activator [160,161] or
Ragi bifunctional inhibitor [162], due to its potential to
rescue misfolded or partially aggregated polypeptide
through its isomerisation activity. In one of the few direct
comparisons of the effects of the two enzymes, the expres-
sion level of insulin-like growth factor-I increased 2-fold
and 1.7-fold, respectively, with DsbA and DsbC [163].
Zhang and co-workers [164] also reported improved solu-
bility of a diverse range of eukaryotic proteins upon fusion
with a DsbA variant lacking active site cysteine residues,
however, which raises the question of whether Dsb pro-
teins aid expression of recombinant proteins due to their
catalytic properties or – as often in the case of PPIases (see
below) – due to a chaperoning capability.
Co-production of DsbBD, DsbAB and DsbAC pairs also
all led to higher functional yields of glutamate racemase
(GluR; [86]) – despite the fact that GluR, while possessing
5 cysteine thiol groups, contains no disulfide bridges in its
native structure. Conversely, expression of human nerve
growth factor [165], horseradish peroxidase [105,166]
and brain-derived neurophilic factor [167] are all more
efficient in the presence of DsbABCD than individual or
pairs of family members.
A number of examples also exist in the literature of co-
production of thioredoxin (Trx), a small (12 kDa) protein
with a Cys-X-X-Cys active site motif, which too is typically
co-produced with cysteine-rich polypeptides. This
approach allowed functional production of a snake
venom thrombin-like enzyme, which in the absence of
Trx was not detectable in the cytoplasm [168], while Trx
also dramatically increased the solubility of mouse c-Myb,
cAMP response element-binding protein 1, p53 tumour
suppressor gene product, adenovirus oncogene product
E1A, Xenopus mos proto-oncogene product and the tyro-
sine kinase Lck, all of which were otherwise produced in
inclusion bodies [65]. Thioredoxin co-production has
also been demonstrated to increase by 3–4 fold the yield
of functional ribotoxin α-sarcin in the E. coli periplasm
[169]. In addition to its use as a separate, co-produced
protein, thioredoxin is commonly employed as a fusionMicrobial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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tag to improve the expression or solubility of heterolo-
gous proteins.
While stable disulfide bridges cannot normally be formed
in the strongly reducing E. coli cytoplasm, there are
increasing attempts to produce disulfide-containing heter-
ologous proteins there, usually by blocking either or both
of the thioredoxin/thioredoxin reductase and glutath-
ione/glutaredoxin reducing pathways. Co-expression of a
leaderless dsbC in such an E. coli background has greatly
enhanced production of antibody fragments [19] and of
proteins with complex disulfide patterns, such as tPA
[161], thrombin-like enzyme calobin [168] and snake
venom fibrolase [170], such that screening of production
of cysteine-rich recombinant proteins that are particularly
prone to aggregation is well-advised in E. coli trx or gor
mutant strains.
Overproduction of periplasmic PPIases
PPIases exist in three distinct families in E. coli: cyclophi-
lins, whose isomerase (rotamase) activity is reversibly
inhibited by cyclosporin A and which are thought to be
essential in processes such as protein folding and subcel-
lular trafficking; FKBPs (FK506 binding proteins), which
are inhibited by FK506 and rapamycin and include the
periplasmic FkpA and cytoplasmic metal-binding SlyD
and trigger factor (discussed above), which is novel
amongst FKBPs in exhibiting no affinity for FK506; and
parvulins, including the periplasmic SurA and membrane-
bound PpiD, which are insensitive to immunosuppres-
sors but irreversibly inhibited by juglone and have roles in
the folding of outer membrane proteins [10]. The three
families exhibit limited sequence and structural similarity
but share a high catalytic activity and a relatively low affin-
ity for nonstructured peptides [171].
Of the 4 PPIases identified in the E. coli periplasm – PpiA
(RotA), PpiD, FkpA and SurA – mutations in PpiA have
been shown to have no effect on the folding of periplas-
mic and outer membrane proteins [172] and PpiA over-
production has failed to improve expression of scFv
fragments or a single-chain TcR [173,174]. There have
been no reports of overproduction of PpiD as an approach
to improving heterologous protein production in E. coli
but the recent report that it interacts with proteins exiting
the SecYEG translocon [175] suggests it may be a promis-
ing target for overexpression with problematic secretory
proteins. SurA, also a parvulin, was found to improve the
folding of unstable or aggregation-prone proteins in the
periplasm [176] but failed to help production of a scFv
fragment [173]. Meanwhile FkpA, which like trigger factor
possesses both chaperone and PPIase activity, enhanced
production of a wide range of scFv fragments by up to 10-
fold when overproduced [173], while its fusion to various
scAb fragments also led to increased solubility and higher
functional yields [177]. FkpA co-production also led to
increased hydrolysis of ampicillin by a catalytic scFv [178]
and enhanced the production of penicillin acylase [179].
Fusion tags
A related approach to improving recombinant protein sol-
ubility, though outside the scope of this review, is the use
of fusion tags, e.g. thioredoxin, maltose-binding protein,
glutathione S-transferase and, more recently, E. coli stress-
responsive proteins such as RpoS [180], SlyD [181], and
PotD and Crr [182]. This strategy generally results in reli-
ably high protein yields and can simplify purification due
to the affinity of certain fusion partners for a particular lig-
and. It also leads to considerations about how the fusion
partner may affect folding or activity and the requirement
for its precise removal, but the general approach has met
with considerable success in increasing protein solubility,
as reviewed elsewhere [183,184].
Overview
Though there are currently no rigid criteria by which one
might identify in silico the "correct" chaperone(s) to over-
come a particular bottleneck in protein production, the
present review identifies the co-production strategies that
have most successfully overcome the major problems lim-
iting recombinant protein yields in E. coli to date. Based
on the current state-of-the-art, therefore, we summarise in
Figure 3 some targeted interventions that might be used to
focus chaperone screening strategies on already proven
approaches, thus increasing the chances of successful pro-
duction of well-behaved, active protein.
Concluding remarks
Co-production of molecular chaperones and folding cata-
lyst improves – very greatly in many cases – the produc-
tion of many heterologous proteins in E. coli. While there
is still no panacea for folding problems, nor even a
rational method to identify the optimal candidate(s) for
co-production with a target of interest, researchers are
increasingly turning to chaperone co-production systems,
available both commercially and non-commercially, as
their first port of call when looking to overcome folding
bottlenecks. While such a multi-chaperone screening
approach can bear fruit quickly and relatively painlessly,
detailed mechanistic studies of individual folding modu-
lators remain essential in order to better understand their
molecular mechanisms for greater, longer term practical
benefits to the field of E. coli recombinant protein produc-
tion.
Finally, though the merit of co-expression of some eukary-
otic chaperones in E. coli is long recognised [185,186], the
immense potential of chaperones from extremophilic spe-
cies has only recently begun to be mined. Successes to date
with GroESL homologues from Oleispira antarctica [187]Microbial Cell Factories 2009, 8:9 http://www.microbialcellfactories.com/content/8/1/9
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and a novel trigger factor from another psychrophile, Psy-
chrobacter frigidicola [188], suggest that these studies may
represent the beginning of a new era in chaperone-assisted
production of recombinant proteins in E. coli.
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